Molecular and clinical features of the TP53 signature gene expression profile in early-stage breast cancer

PURPOSE: TP53 signature has a robust predictive performance for prognosis in early-stage breast cancer, but the experiment that reported this relied on public microarray data and fresh-frozen samples. Before TP53 signature can be used in a clinical setting, a simple and low-cost diagnostic system us...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamaguchi, Shigeo, Takahashi, Shin, Mogushi, Kaoru, Izumi, Yuki, Nozaki, Yumi, Nomizu, Tadashi, Kakugawa, Yoichiro, Ishida, Takanori, Ohuchi, Noriaki, Ishioka, Chikashi, Kato, Shunsuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865663/
https://www.ncbi.nlm.nih.gov/pubmed/29581837
http://dx.doi.org/10.18632/oncotarget.24447

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865663/
https://www.ncbi.nlm.nih.gov/pubmed/29581837
http://dx.doi.org/10.18632/oncotarget.24447

Ejemplares similares